Is Sorafenib included in medical insurance?

Sorafenib is a targeted anti-cancer drug that is a possible treatment for a type of liver cancer called hepatocellular carcinoma, certain types of thyroid cancer when radioactive iodine therapy doesn't work, and advanced kidney cancer. Sorafenib is a protein kinase inhibitor. This means that it blocks certain enzymes called protein kinases. These enzymes can be found in receptors on the surface of cancer cells, where they are involved in the growth and spread of cancer cells, and in the blood vessels that feed tumors, where they are involved in the development of new blood vessels.

By blocking specific enzymes of these protein kinases, sorafenib can reduce the growth of cancer cells and cut off the blood supply that keeps them growing. Sorafenib is a tablet that is usually taken twice daily with a glass of water and should usually be taken without food or with a low-fat meal. High-fat foods may make sorafenib less effective. If you want to eat high-fat foods, take it at least 1 hour before or 2 hours after a meal.

SorafenibThe original drug has been launched in China and has entered the scope of medical insurance. Different regions have different reimbursement ratios, and the price after reimbursement may vary. SpecificationsThe price of 0.2g*60 tablets may be around RMB 1,200. The original drug of sorafenib has also been launched overseas, and there are also sorafenib generic drugs produced in other countries. The specifications produced by Bangladesh Pharmaceutical FactoryThe price of 0.2g*60 tablets is around 450 yuan (the price may fluctuate due to the exchange rate). The pharmaceutical ingredients of the original drug are basically the same as those of the generic drugs. For specific prices and drug details, please consult the medical consultant of Yaode.